Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP173256.RAKymx3Uy80jfsJuEJR3y2rsPgn4n-RYpD1S-T_x-gadc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP173256.RAKymx3Uy80jfsJuEJR3y2rsPgn4n-RYpD1S-T_x-gadc130_assertion type Assertion NP173256.RAKymx3Uy80jfsJuEJR3y2rsPgn4n-RYpD1S-T_x-gadc130_head.
- NP173256.RAKymx3Uy80jfsJuEJR3y2rsPgn4n-RYpD1S-T_x-gadc130_assertion description "[DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP173256.RAKymx3Uy80jfsJuEJR3y2rsPgn4n-RYpD1S-T_x-gadc130_provenance.
- NP173256.RAKymx3Uy80jfsJuEJR3y2rsPgn4n-RYpD1S-T_x-gadc130_assertion evidence source_evidence_literature NP173256.RAKymx3Uy80jfsJuEJR3y2rsPgn4n-RYpD1S-T_x-gadc130_provenance.
- NP173256.RAKymx3Uy80jfsJuEJR3y2rsPgn4n-RYpD1S-T_x-gadc130_assertion SIO_000772 17965955 NP173256.RAKymx3Uy80jfsJuEJR3y2rsPgn4n-RYpD1S-T_x-gadc130_provenance.
- NP173256.RAKymx3Uy80jfsJuEJR3y2rsPgn4n-RYpD1S-T_x-gadc130_assertion wasDerivedFrom lhgdn-20090331 NP173256.RAKymx3Uy80jfsJuEJR3y2rsPgn4n-RYpD1S-T_x-gadc130_provenance.
- NP173256.RAKymx3Uy80jfsJuEJR3y2rsPgn4n-RYpD1S-T_x-gadc130_assertion wasGeneratedBy ECO_0000203 NP173256.RAKymx3Uy80jfsJuEJR3y2rsPgn4n-RYpD1S-T_x-gadc130_provenance.